{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:47Z","timestamp":1786118867274,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,15]]},"DOI":"10.1097\/tp.0b013e318188af15","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T03:24:52Z","timestamp":1226287492000},"page":"1241-1248","source":"Crossref","is-referenced-by-count":66,"title":["Efficacy and Safety of Basiliximab in Pediatric Renal Transplant Patients Receiving Cyclosporine, Mycophenolate Mofetil, and Steroids"],"prefix":"10.1097","volume":"86","author":[{"given":"Gisela","family":"Offner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Toenshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"H\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Fehrenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Foulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese C.","family":"Jungraithmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Latta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Leichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mihatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Misselwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"M\u00fcller-Wiefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Plank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Schwarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Wygoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar B.","family":"Zimmerhackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00376.x","article-title":"Chronic renal allograft rejection: Pathophysiologic considerations.","volume":"68","author":"Joosten","year":"2005","journal-title":"Kidney Int"},{"key":"R2-14-20210129","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-14-20210129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3046.2005.00303.x","article-title":"Anti-IL-2 receptor antibody vs. polyclonal anti- lymphocyte antibody as induction therapy in pediatric transplantation.","volume":"9","author":"Di Filippo","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R4-14-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients.","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"R5-14-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody.","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"R6-14-20210129","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00007890-200110150-00014","article-title":"A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients.","volume":"72","author":"Ponticelli","year":"2001","journal-title":"Transplantation"},{"key":"R7-14-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007890-199901150-00019","article-title":"Reduction of acute renal allograft rejection by daclizumab.","volume":"67","author":"Nashan","year":"1999","journal-title":"Transplantation"},{"key":"R8-14-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","article-title":"Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation.","volume":"338","author":"Vincenti","year":"1998","journal-title":"N Engl J Med"},{"key":"R9-14-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti- interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.","volume":"75","author":"Lawen","year":"2003","journal-title":"Transplantation"},{"key":"R10-14-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1399-0012.2003.00079.x","article-title":"Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.","volume":"17","author":"Pescovitz","year":"2003","journal-title":"Clin Transplant"},{"key":"R12-14-20210129","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/00007890-200210150-00011","article-title":"A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations.","volume":"74","author":"Kovarik","year":"2002","journal-title":"Transplantation"},{"key":"R14-14-20210129","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00007890-200210150-00010","article-title":"A multicenter, open-label, pharmacokinetic\/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients.","volume":"74","author":"Offner","year":"2002","journal-title":"Transplantation"},{"key":"R15-14-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1034\/j.1399-3046.2001.005004297.x","article-title":"Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients.","volume":"5","author":"Vester","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R16-14-20210129","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1600-6143.2006.01367.x","article-title":"A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation.","volume":"6","author":"Grenda","year":"2006","journal-title":"Am J Transplant"},{"key":"R17-14-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0041-1345(03)00578-5","article-title":"Immunoprophylaxis with Simulect (basiliximab) in pediatric kidney transplant recipients: Results from routine clinical practice at 5 kidney transplant units.","volume":"35","author":"Garcia Meseguer","year":"2003","journal-title":"Transplant Proc"},{"key":"R18-14-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1399-3046.2005.00267.x","article-title":"Mycophenolate mofetil in pediatric renal transplantation: Non-induction vs. induction with basiliximab.","volume":"9","author":"Ojogho","year":"2005","journal-title":"Pediatr Transplant"},{"key":"R19-14-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.transproceed.2005.02.022","article-title":"Open-label, multicenter study on the safety, tolerability, and efficacy of Simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids.","volume":"37","author":"Turconi","year":"2005","journal-title":"Transplant Proc"},{"key":"R20-14-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R21-14-20210129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","article-title":"The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.","volume":"34","author":"Schwartz","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"R22-14-20210129","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3201\/eid1102.040820","article-title":"Molecular evidence of pneumocystis transmission in pediatric transplant unit.","volume":"11","author":"Hocker","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R23-14-20210129","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00007890-200103150-00010","article-title":"Mycophenolate mofetil in pediatric renal transplantation without induction therapy: Results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.","volume":"71","author":"Staskewitz","year":"2001","journal-title":"Transplantation"},{"key":"R24-14-20210129","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.tp.0000258587.70166.87","article-title":"Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation.","volume":"83","author":"Jungraithmayr","year":"2007","journal-title":"Transplantation"},{"key":"R25-14-20210129","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.TP.0000045748.95874.64","article-title":"Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: Results after three years.","volume":"75","author":"Jungraithmayr","year":"2003","journal-title":"Transplantation"},{"key":"R26-14-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1432-2277.2006.00321.x","article-title":"Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant patients.","volume":"19","author":"Vincenti","year":"2006","journal-title":"Transplant Int"},{"key":"R28-14-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.TP.0000133536.83756.1F","article-title":"Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: Results after four years.","volume":"78","author":"Hocker","year":"2004","journal-title":"Transplantation"},{"key":"R29-14-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-3046.2006.00577.x","article-title":"Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity [Review].","volume":"10","author":"Tonshoff","year":"2006","journal-title":"Pediatr Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e318188af15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:40Z","timestamp":1786036300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200811150-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,15]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318188af15","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11,15]]}}}